generations of glp 1 agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Multifaceted Roles of GLP-1 and
Description
Conversely, constipation has been shown to persist longer than other GI side effects and is more frequently observed in obesity-focused studies

Furthermore, it has long been theorized that cancer cells exhibit heightened glucose uptake and rely on glucose as a primary fuel for proliferation because it is a substrate cancer cells use as an energy source in aerobic glycolysis, resulting in tumor progression [27]

While semaglutide will remain under patent in many regions until the early 2030s, the first generic versions are expected to launch in India imminently, with additional market entries anticipated in China, Canada, Brazil, Turkey, and South Africa in the months that follow

That would mean a 2027 launch

GLP-1 is both anxiogenic and antidepressant

Oncol Rep
